current status17 Apr 2020 10:26
I have this valued at around 19pence as is. This means with FDA approval which is a likely but not a given we would rise from there. That would be very much based on orders, speed of production and global depth of order. if you add Salarius to this we go live in May, so genuine income from a started (northeast supply chain) perspective. Add to this a key player coming in to add our salt to their burgers, crisps, bar snacks, plane foods, or a US coverage spread happening this could add potentially $5-10mln in just profits per quarter. Id say that takes 6 month valuation back to 40pence. So, for all the people having a mardy because the short term (1 week ) compression isnt to their liking, even though people are buying and we have dropped off a tiny amount, just get out. Leave this share to genuine players who have been in for years who are finally seeing the true value and appreciate it very much. I salute the board, the RNS culture is fantastic, the hires and of course the projects. this is only going up. DYOR and always IMO. GLA